Senti Biosciences Inc (SNTI)

Jul 22, 2025

What analysts say about Senti Biosciences Inc. stockAccelerated profit realization - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What drives Senti Biosciences Inc. stock priceAccelerated capital growth - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Senti Biosciences Participates in the Virtual Investor 'What’s Your Story” Summer Spotlight On-Demand Conference - The Manila Times

Jul 22, 2025

Jul 22, 2025

Exclusive: Senti Bio CEO Reveals Personal Journey and Strategic Vision for Gene Circuit Platform - Stock Titan

Jul 22, 2025

Jul 22, 2025

Senti Biosciences Inc. Stock Analysis and ForecastFree Stock Market Return Analysis - jammulinksnews.com

Jul 22, 2025

Jul 21, 2025

What makes Senti Biosciences Inc. stock price move sharplyPro Trader Stock Focus - Newser

Jul 21, 2025

Jul 21, 2025

Solid Biosciences Inc. shares rise 3.29% premarket after Senti Bio's presentation at BioScience Forum. - AInvest

Jul 21, 2025

Jul 21, 2025

Senti Bio’s Chief Medical Officer, Kanya Rajangam, M.D., Ph.D. to Give Feature Presentation at the BioScience Forum - The Manila Times

Jul 21, 2025

Jul 21, 2025

Senti Bio to present logic-gated CAR-NK cell therapy at BioScience Forum - Investing.com

Jul 21, 2025

Jul 21, 2025

Why Senti Biosciences Inc. stock attracts strong analyst attentionFree Step-by-Step Investment Guide - beatles.ru

Jul 21, 2025

Jul 20, 2025

Is Senti Biosciences Inc. a good long term investmentRemarkably fast returns - PrintWeekIndia

Jul 20, 2025

Jul 19, 2025

Senti Bio Appoints Bryan Baum to Board of Directors, Aims for Growth with New Expertise. - AInvest

Jul 19, 2025

Jul 19, 2025

Senti Biosciences Appoints Bryan Baum to Board, Enhancing Strategic Direction and Optimizing Value for Stakeholders - AInvest

Jul 19, 2025

Jul 18, 2025

Bryan Baum Joins Senti Biosciences Board of Directors - AInvest

Jul 18, 2025

Jul 18, 2025

Sweetgreen, Inc. shares rise 3.77% intraday after Senti Biosciences, Inc. appoints Bryan Baum to its Board of Directors. - AInvest

Jul 18, 2025

Jul 18, 2025

Senti Biosciences Appoints Bryan Baum to Board - TipRanks

Jul 18, 2025

Jul 18, 2025

Senti Bio appoints K5 Global co-founder Bryan Baum to board of directors By Investing.com - Investing.com South Africa

Jul 18, 2025

Jul 18, 2025

Senti Bio appoints K5 Global co-founder Bryan Baum to board of directors - Investing.com

Jul 18, 2025

Jul 18, 2025

Senti Bio Appoints Entrepreneurial Leader and Investor, Bryan Baum, to Board of Directors - The Manila Times

Jul 18, 2025

Jul 18, 2025

Is Senti Biosciences Inc. stock overhyped or has real potentialLow Risk ROI Maximization - Newser

Jul 18, 2025

Jul 15, 2025

How Senti Biosciences Inc. stock performs during market volatilityStrong Buy Recommendations - Newser

Jul 15, 2025

Jul 14, 2025

SNTI’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com

Jul 14, 2025

Jul 14, 2025

Senti Biosciences Stock Faces Decline Amid Market Challenges - timothysykes.com

Jul 14, 2025

Jul 14, 2025

Senti Biosciences Soars 32.39% on Promising Clinical Trial Results - AInvest

Jul 14, 2025

Jul 12, 2025

Senti Biosciences (NASDAQ:SNTI) Upgraded by Wall Street Zen to “Sell” Rating - Defense World

Jul 12, 2025

Jul 04, 2025

Senti Biosciences (NASDAQ:SNTI) Trading Up 2.5% – Here’s What Happened - Defense World

Jul 04, 2025

Jun 30, 2025

Senti Biosciences Holds 2025 Annual Stockholders Meeting - TipRanks

Jun 30, 2025

Jun 30, 2025

Senti Bio Participates in Nasdaq Amplify Spotlight Series - TradingView

Jun 30, 2025

Jun 30, 2025

Senti Biosciences, Inc.(NasdaqCM: SNTI) added to Russell 3000E Value Index - MarketScreener

Jun 30, 2025

Jun 28, 2025

SNTI SEC FilingsSenti Bioscience 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 28, 2025

Jun 25, 2025

Is Senti Biosciences, Inc. overvalued or undervalued? - MarketsMojo

Jun 25, 2025

Jun 24, 2025

Senti Bio Reveals Next-Gen Logic-Gated Cell Technology for Precision Cancer Treatment at SEED 2025 - Stock Titan

Jun 24, 2025

Jun 19, 2025

FDA Grants Orphan Drug Designation to SENTI-202 for R/R AML - Targeted Oncology

Jun 19, 2025

Jun 18, 2025

Senti Biosciences Inc (SNTI) Stock: Uncovering 52-Week Market Trends - investchronicle.com

Jun 18, 2025

Jun 18, 2025

Senti Bio Receives US FDA Orphan Drug Designation for Potential Blood Cancer Treatment - MarketScreener

Jun 18, 2025

Jun 18, 2025

Senti Biosciences, Inc. Reports Progress in Phase 1 Trial of SENTI-202 for Acute Myeloid Leukemia, Receives Orphan Drug Designation - Nasdaq

Jun 18, 2025

Jun 18, 2025

FDA grants orphan drug designation to Senti Bio’s AML treatment - Investing.com

Jun 18, 2025

Jun 18, 2025

FDA Backs Senti Bio Revolutionary Cancer Drug as 60% of AML Patients Face Critical Outcomes - Stock Titan

Jun 18, 2025

Jun 18, 2025

Senti Biosciences Soars 7.91% on FDA Orphan Drug Designation - AInvest

Jun 18, 2025

Jun 13, 2025

Senti Biosciences (NASDAQ:SNTI) Receives Buy Rating from Chardan Capital - Defense World

Jun 13, 2025

Jun 12, 2025

Senti Biosciences (SNTI) Rating and Price Target Updated by Chardan Capital | SNTI Stock News - GuruFocus

Jun 12, 2025

Jun 10, 2025

Senti Biosciences Announces New Employment Inducement Grants - The Manila Times

Jun 10, 2025

Jun 09, 2025

Gene Circuit Pioneer Senti Bio Grants $310K in Stock Options to Expand Next-Gen Therapy Team - Stock Titan

Jun 09, 2025